{"entity":{"type":"insider","cik":"0001516354","url":"/insider/0001516354","json_url":"/insider/0001516354.json","name":"Roberts Brandi","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":6,"n_filings":5,"first":"2015-03-30","last":"2026-06-26","span_basis":"filed_date"},"name_variants":[{"name":"Roberts Brandi","source":"filing","n_filings":5,"first_seen":"2015-03-30","last_seen":"2026-06-26"}],"transactions":[{"id":5751478,"accession":"0001193125-26-285563","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-26-285563","line_url":"/filing/0001193125-26-285563#line-1","is_derivative":false,"issuer_cik":"0001516354","issuer_name":"Definium Therapeutics, Inc.","issuer_ticker":"DFTX","issuer_name_source":null,"issuer_url":"/issuer/0001516354","owner_cik":"0001516354","owner_name":"Roberts Brandi","owner_display_name":"Roberts Brandi","owner_url":"/insider/0001516354","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3013.0,"shares_display":"3,013","price_per_share":45.03,"price_display":"45.03","price_state":"stated","total_value":135675.39,"total_display":"135,675.39","total_whole":"135,675","shares_owned_after":209487.0,"shares_owned_after_display":"209,487","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-25","filed_date":"2026-06-26","scope":"insider"},{"id":8442190,"accession":"0001213900-23-067444","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-23-067444","line_url":"/filing/0001213900-23-067444#line-1","is_derivative":false,"issuer_cik":"0001516354","issuer_name":"TFF Pharmaceuticals, Inc.","issuer_ticker":"TFFP","issuer_name_source":null,"issuer_url":"/issuer/0001516354","owner_cik":"0001516354","owner_name":"Roberts Brandi","owner_display_name":"Roberts Brandi","owner_url":"/insider/0001516354","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":0.25,"price_display":"0.25","price_state":"stated","total_value":5000.0,"total_display":"5,000.00","total_whole":"5,000","shares_owned_after":20000.0,"shares_owned_after_display":"20,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-15","filed_date":"2023-08-15","scope":"insider"},{"id":8205970,"accession":"0001209191-19-046030","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-046030","line_url":"/filing/0001209191-19-046030#line-1","is_derivative":false,"issuer_cik":"0000876343","issuer_name":"Lineage Cell Therapeutics, Inc.","issuer_ticker":"LCTX","issuer_name_source":null,"issuer_url":"/issuer/0000876343","owner_cik":"0001516354","owner_name":"Roberts Brandi","owner_display_name":"Roberts Brandi","owner_url":"/insider/0001516354","role":"Officer (CFO & SVP, Finance)","role_mark":"O","role_mark_label":"Officer (CFO & SVP, Finance)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO & SVP, Finance","security_title":"Common Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":1.01,"price_display":"1.01","price_state":"stated","total_value":5050.0,"total_display":"5,050.00","total_whole":"5,050","shares_owned_after":5000.0,"shares_owned_after_display":"5,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-13","filed_date":"2019-08-15","scope":"insider"},{"id":6802936,"accession":"0001209191-18-040512","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-040512","line_url":"/filing/0001209191-18-040512#line-1","is_derivative":false,"issuer_cik":"0001496268","issuer_name":"REVA Medical, Inc.","issuer_ticker":"RVA.AX","issuer_name_source":null,"issuer_url":"/issuer/0001496268","owner_cik":"0001516354","owner_name":"Roberts Brandi","owner_display_name":"Roberts Brandi","owner_url":"/insider/0001516354","role":"Officer (SVP & Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (SVP & Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4907.9,"shares_display":"4,907.90","price_per_share":1.53,"price_display":"1.53","price_state":"stated","total_value":7509.087,"total_display":"7,509.09","total_whole":"7,509","shares_owned_after":54907.9,"shares_owned_after_display":"54,907.90","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-06-29","filed_date":"2018-07-02","scope":"insider"},{"id":8938221,"accession":"0001209191-15-030054","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-030054","line_url":"/filing/0001209191-15-030054#line-2","is_derivative":false,"issuer_cik":"0001160308","issuer_name":"Mast Therapeutics, Inc.","issuer_ticker":"MSTX","issuer_name_source":null,"issuer_url":"/issuer/0001160308","owner_cik":"0001516354","owner_name":"Roberts Brandi","owner_display_name":"Roberts Brandi","owner_url":"/insider/0001516354","role":"Officer (Chief Financial Officer & SVP)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer & SVP)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer & SVP","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":18000.0,"shares_display":"18,000","price_per_share":0.4972,"price_display":"0.50","price_state":"stated","total_value":8949.6,"total_display":"8,949.60","total_whole":"8,950","shares_owned_after":38000.0,"shares_owned_after_display":"38,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-03-27","filed_date":"2015-03-30","scope":"insider"},{"id":8938218,"accession":"0001209191-15-030054","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-030054","line_url":"/filing/0001209191-15-030054#line-1","is_derivative":false,"issuer_cik":"0001160308","issuer_name":"Mast Therapeutics, Inc.","issuer_ticker":"MSTX","issuer_name_source":null,"issuer_url":"/issuer/0001160308","owner_cik":"0001516354","owner_name":"Roberts Brandi","owner_display_name":"Roberts Brandi","owner_url":"/insider/0001516354","role":"Officer (Chief Financial Officer & SVP)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer & SVP)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer & SVP","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":0.5016,"price_display":"0.50","price_state":"stated","total_value":10032.0,"total_display":"10,032.00","total_whole":"10,032","shares_owned_after":20000.0,"shares_owned_after_display":"20,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-03-26","filed_date":"2015-03-30","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":6,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":5,"open_market":true},{"code":"S","label":"Open-market sale","n":1,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":6},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001813814","name":"Definium Therapeutics, Inc.","url":"/issuer/0001813814","role":"Officer (Chief Financial Officer)","n_filings":1,"first_seen":"2026-06-26","last_seen":"2026-06-26"},{"type":"issuer","type_label":"ISSUER","cik":"0001733413","name":"TFF Pharmaceuticals, Inc.","url":"/issuer/0001733413","role":"Director","n_filings":1,"first_seen":"2023-08-15","last_seen":"2023-08-15"},{"type":"issuer","type_label":"ISSUER","cik":"0000876343","name":"Lineage Cell Therapeutics, Inc.","url":"/issuer/0000876343","role":"Officer (CFO & SVP, Finance)","n_filings":1,"first_seen":"2019-08-15","last_seen":"2019-08-15"},{"type":"issuer","type_label":"ISSUER","cik":"0001496268","name":"REVA Medical, Inc.","url":"/issuer/0001496268","role":"Officer (SVP & Chief Financial Officer)","n_filings":1,"first_seen":"2018-07-02","last_seen":"2018-07-02"},{"type":"issuer","type_label":"ISSUER","cik":"0001160308","name":"Mast Therapeutics, Inc.","url":"/issuer/0001160308","role":"Officer (Chief Financial Officer & SVP)","n_filings":1,"first_seen":"2015-03-30","last_seen":"2015-03-30"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001516354","retrieved_at":"2026-08-23T18:15:51+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}